Fresh insights from the Psychedelic Therapeutics & Drug Development Conference in New Orleans. In this interview, psychiatrist Brian Barnett discusses the horizon of psychedelic therapies and what it may take for these treatments to become available to patients. As psychedelic therapies approach regulatory milestones, the key question is no longer only efficacy, but how these treatments will actually be delivered safely and at scale. Part of Cascades Analytics’ live conference coverage, in partnership with Arrowhead SciTech Conferences & Events.